scholarly journals Targeting USP13 mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in Non‐Small Cell Lung Cancer

2020 ◽  
Author(s):  
Philippe Giron ◽  
Carolien Eggermont ◽  
Amir Noeparast ◽  
Hugo Vandenplas ◽  
Erik Teugels ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Drug Tolerance ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Inhibition ◽  
Mutant Egfr

scholarly journals Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non–Small Cell Lung Cancer Cells

2014 ◽  
Vol 20 (21) ◽  
pp. 5423-5434 ◽  
Author(s):  
Akriti Kharbanda ◽  
Hasan Rajabi ◽  
Caining Jin ◽  
Jeremy Tchaicha ◽  
Eiki Kikuchi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
C Protein ◽  
Mutant Egfr

scholarly journals A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

Oncotarget ◽  
2015 ◽  
Vol 6 (29) ◽  
pp. 26814-26825 ◽  
Author(s):  
Alessandro Russo ◽  
Tindara Franchina ◽  
Giuseppina Rosaria Rita Ricciardi ◽  
Antonio Picone ◽  
Giuseppa Ferraro ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Future Perspectives ◽  
Small Cell Lung ◽  
Egfr Inhibition ◽  
Egfr Mutated

13 Acquired resistance to EGFR inhibition: evolution from adenocarcinoma to small cell lung cancer (SCLC)

Lung Cancer ◽  
2013 ◽  
Vol 79 ◽  
pp. S5
Author(s):  
C. Moss ◽  
P. Cane ◽  
E. Mclean ◽  
G. Santis ◽  
K. Tobal ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Acquired Resistance ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Inhibition

scholarly journals A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer

2016 ◽  
Vol 27 (12) ◽  
pp. 2300-2301 ◽  
Author(s):  
S. Nishikawa ◽  
Y. Tambo ◽  
H. Ninomiya ◽  
T. Oguri ◽  
Y. Kawashima ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mutant Egfr

scholarly journals Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer

Oncotarget ◽  
2013 ◽  
Vol 4 (1) ◽  
pp. 118-127 ◽  
Author(s):  
Gerald S. Falchook ◽  
Aung Naing ◽  
David S. Hong ◽  
Ralph Zinner ◽  
Siqing Fu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase I Clinical Trial ◽  
Small Cell Lung ◽  
Egfr Inhibition ◽  
Anti Vegf

scholarly journals Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR

2018 ◽  
Vol 39 (5) ◽  
pp. 719-727 ◽  
Author(s):  
Hidejiro Torigoe ◽  
Hiromasa Yamamoto ◽  
Masakiyo Sakaguchi ◽  
Chen Youyi ◽  
Kei Namba ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Suppressive Effect ◽  
Small Cell ◽  
Negative Regulator ◽  
Small Cell Lung ◽  
Tumor Suppressive Effect ◽  
Mutant Egfr
Sign in / Sign up

Export Citation Format

Share Document